WORK Medical Technology Group (NASDAQ:WOK) has announced a strategic partnership with the Wuxi Branch of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine (Xin Rui Hospital) to develop AI-powered medical solutions. Through its subsidiary Work Hangzhou, the company will support Xin Rui Hospital in advancing hospital informatization and AI applications.
The collaboration aims to integrate AI technology with Xin Rui Hospital’s multimodal medical resources, including text, imaging, and laboratory data. Work Hangzhou plans to enhance its multimodal universal medical AI solution by expanding from single-image data to complex multimodal data. The partnership will focus on data governance, model training, and clinical practice implementation.
WORK Medical Technology Group (NASDAQ:WOK) ha annunciato una partnership strategica con la filiale di Wuxi del Ruijin Hospital della Shanghai Jiao Tong University School of Medicine (Xin Rui Hospital) per sviluppare soluzioni mediche basate sull’intelligenza artificiale. Attraverso la controllata Work Hangzhou, l’azienda supporterà Xin Rui Hospital nel progresso dell’informatizzazione ospedaliera e delle applicazioni AI.
La collaborazione punta a integrare la tecnologia AI con le risorse mediche multimodali di Xin Rui Hospital, tra cui dati testuali, di imaging e di laboratorio. Work Hangzhou intende ampliare la sua soluzione AI medica universale multimodale passando dall’analisi di immagini singole a dati multimodali complessi. L’alleanza si concentrerà su governance dei dati, addestramento dei modelli e implementazione nella pratica clinica.
WORK Medical Technology Group (NASDAQ:WOK) ha anunciado una asociación estratégica con la sucursal de Wuxi del Ruijin Hospital–Shanghai Jiao Tong University School of Medicine (Xin Rui Hospital) para desarrollar soluciones médicas impulsadas por IA. A través de su filial Work Hangzhou, la empresa apoyará a Xin Rui Hospital en el avance de la informatización hospitalaria y de las aplicaciones de IA.
La colaboración busca integrar la tecnología IA con los recursos médicos multimodales de Xin Rui Hospital, que incluyen datos de texto, imágenes y laboratorio. Work Hangzhou planea ampliar su solución de IA médica multimodal universal, pasando de datos de una sola imagen a datos multimodales complejos. La asociación se centrará en la gobernanza de datos, el entrenamiento de modelos y la implementación en la práctica clínica.
WORK Medical Technology Group (NASDAQ:WOK)은 상하이 교통대 의과대학 류진병원(신뤼 병원)의 우시 지사와 AI 기반 의료 솔루션 개발을 위한 전략적 파트너십을 발표했습니다. 자회사 Work Hangzhou를 통해 Xin Rui Hospital의 병원 정보화 및 AI 애플리케이션 발전을 지원할 예정입니다.
협력은 Xin Rui Hospital의 텍스트, 영상 및 검사 데이터 등 다중 모달 의료 자원을 AI 기술과 통합하는 것을 목표로 합니다. Work Hangzhou는 단일 영상 데이터에서 복합 다중 모달 데이터로 확장하여 다중 모달용 보편적 의료 AI 솔루션을 강화할 계획입니다. 파트너십의 핵심은 데이터 거버넌스, 모델 학습, 임상 적용의 구현에 집중됩니다.
WORK Medical Technology Group (NASDAQ:WOK) a annoncé un partenariat stratégique avec la branche de Wuxi du Ruijin Hospital–Shanghai Jiao Tong University School of Medicine (Xin Rui Hospital) pour développer des solutions médicales basées sur l’IA. Via sa filiale Work Hangzhou, l’entreprise soutiendra Xin Rui Hospital dans l’avancement de l’informatisation hospitalière et des applications d’IA.
La collaboration vise à intégrer la technologie IA avec les ressources médicales multimodales de Xin Rui Hospital, comprenant des données textuelles, d’imagerie et de laboratoire. Work Hangzhou prévoit d’étendre sa solution d’IA médicale multimodale universelle en passant de données d’image unique à des données multimodales complexes. Le partenariat se concentrera sur la gouvernance des données, la formation des modèles et l’implémentation en pratique clinique.
WORK Medical Technology Group (NASDAQ:WOK) hat eine strategische Partnerschaft mit der Wuxi-Niederlassung des Ruijin Hospitals der Shanghai Jiao Tong University School of Medicine (Xin Rui Hospital) angekündigt, um KI-gestützte medizinische Lösungen zu entwickeln. Über die Tochtergesellschaft Work Hangzhou wird das Unternehmen Xin Rui Hospital bei der Weiterentwicklung der Krankenhausinformatik und KI-Anwendungen unterstützen.
Die Zusammenarbeit zielt darauf ab, KI-Technologie in die multimodalen medizinischen Ressourcen des Xin Rui Hospitals zu integrieren, darunter Text-, Bild- und Labordaten. Work Hangzhou plant, seine universelle multimodale medizinische KI-Lösung von Einzeldaten hin zu komplexen multimodalen Daten zu erweitern. Die Partnerschaft wird sich auf Daten Governance, Modelltraining und Implementierung in der klinischen Praxis konzentrieren.
WORK Medical Technology Group (NASDAQ:WOK) أعلنت عن شراكة استراتيجية مع فرع ووتشي من مستشفى رونجين-جامعة شنغهاي للطب (Xin Rui Hospital) لتطوير حلول طبية مدعومة بالذكاء الاصطناعي. من خلال شركتها الفرعية Work Hangzhou، ستدعم الشركة Xin Rui Hospital في تعزيز توثيق المعلوماتية بالمستشفى وتطبيقات الذكاء الاصطناعي.
يهدف التعاون إلى دمج تكنولوجيا AI مع موارد Xin Rui Hospital الطبية متعددة الوسائط، بما في ذلك البيانات النصية والمرئية والبيانات المخبرية. تخطط Work Hangzhou لتعزيز حلها الطبي المتعدد الوسائط الشامل من بيانات صورة واحدة إلى بيانات متعددة الوسائط المعقدة. ستتركز الشراكة على حوكمة البيانات، وتدريب النماذج، وتنفيذ الممارسة السريرية.
WORK Medical Technology Group (NASDAQ:WOK)宣布与上海交通大学医学院附属瑞金医院（新瑞医院）无锡分院建立战略伙伴关系，以开发由人工智能驱动的医疗解决方案。通过其子公司 Work Hangzhou，该公司将支持新瑞医院在医院信息化和 AI 应用方面的推进。
此次合作旨在将 AI 技术与新瑞医院的多模态医疗资源相结合，包括文本、影像和实验室数据。Work Hangzhou 计划通过将数据从单张图像扩展到复杂的多模态数据，提升其多模态通用医疗 AI 解决方案。伙伴关系将重点关注 数据治理、模型训练和临床实践落地。
Positive
- Strategic partnership with a prestigious Grade 3-Class B tertiary hospital affiliated with Shanghai Jiao Tong University
- Access to comprehensive clinical data and practical environment for AI development
- Potential expansion of technology solution adoption in domestic hospitals
- Development of advanced multimodal AI solutions beyond single-image data
Negative
- No immediate revenue impact disclosed
- Implementation timeline and specific milestones not provided
- Potential development and integration costs not disclosed
Insights
WORK Medical’s AI partnership with Xin Rui Hospital represents a strategic advancement into healthcare AI that could significantly expand its market presence.
This partnership between WORK Medical and Xin Rui Hospital marks a significant strategic pivot toward AI-driven healthcare solutions. The collaboration aims to develop multimodal AI applications that integrate various data types—including imaging, text, and laboratory data—moving beyond single-image analysis to more comprehensive healthcare applications.
The strategic value lies in WORK Medical gaining access to real-world clinical data and testing environments through Xin Rui Hospital, which is affiliated with one of China’s premier medical institutions. This provides the company with valuable resources for AI model training that would otherwise be difficult to obtain. For context, high-quality medical data access remains one of the largest barriers to entry in healthcare AI development.
From a competitive standpoint, this partnership positions WORK Medical to potentially expand beyond its current medical device supplier role into the higher-margin healthcare software and AI solutions market. The collaboration could accelerate the company’s technology development cycle by providing immediate feedback loops from clinical settings.
While the announcement doesn’t specify financial terms or revenue projections, the emphasis on “unlocking new opportunities and long-term value” signals the company’s view that this represents a meaningful strategic initiative rather than merely a research project. The partnership aligns with broader industry trends toward AI-enhanced clinical decision support systems and hospital digitalization in China’s healthcare market, which is undergoing rapid technological transformation.
Hangzhou, China, Sept. 22, 2025 (GLOBE NEWSWIRE) — WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. (“Work Hangzhou”) and its subsidiaries in China, today announced the signing of a strategic cooperation agreement (the “Agreement”) between Work Hangzhou and the Wuxi Branch of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine (“Xin Rui Hospital”) to jointly develop medical products utilizing artificial intelligence (the “AI”). This collaboration represents an initiative in advancing WORK Medical’s AI strategy, with the goal of accelerating the development of a next-generation, AI-driven smart clinical ecosystem.
Pursuant to the Agreement, Work Hangzhou agrees to support Xin Rui Hospital in advancing hospital informatization and the application of AI-powered medical products. Both parties aim to integrate AI technology with Xin Rui Hospital’s multimodal medical resources, including text, imaging, and laboratory data, to build a digital knowledge base for intelligent healthcare. With Xin Rui Hospital’s clinical diagnostic, treatment and expert resources, Work Hangzhou also plans to enhance its multimodal universal medical AI solution, expanding from single-image data to complex multimodal data. The collaboration is expected to drive the development, training and clinical application of AI models across multiple healthcare scenarios, as both parties endeavor to create a comprehensive framework covering data governance, model training and the translation of research into clinical practice.
Xin Rui Hospital, located in Wuxi, Jiangsu Province, China, is a Grade 3-Class B tertiary hospital affiliated with Ruijin Hospital–Shanghai Jiao Tong University School of Medicine, one of China’s premier Grade 3-Class A tertiary hospitals and a National Clinical Research Center designated by the National Health Commission.
Mr. Wu Shuang, chief executive officer and chairman of WORK Medical, commented: “We are delighted to partner with Xin Rui Hospital. By combining our expertise with Xin Rui Hospital’s clinical data and practical environment, we aim to establish a model for hospital digitalization and intelligent healthcare applications. We expect this collaboration to accelerate the AI transformation of domestic hospitals, broaden the adoption of our technology solutions, promote the development of AI-driven healthcare, and unlock new opportunities and long-term value for WORK Medical.”
About WORK Medical Technology Group LTD
WORK Medical Technology Group LTD, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, is a supplier of medical devices that develops and manufactures Class I and II medical devices and sells Class I and II disposable medical devices through operating subsidiaries in China. The Company has a diverse product portfolio comprising 21 products, including customized and multifunctional masks and other medical consumables. All the products have been sold in 34 provincial-level administrative regions in China, with 15 of them sold in more than 30 countries worldwide. The Company has received a number of quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration allowing their products to enter the U.S. market. For more information, please visit the Company’s website: https://www.workmedtech.com/corporate.
Forward-Looking Statements
This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will,” and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Any forward-looking statements in this press release are based on the Company’s current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results set forth in the Company’s annual report on Form 20-F and other documents filed by the Company with the U.S. Securities and Exchange Commission. The Company explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.
For more information, please contact:
WORK Medical Technology Group LTD
Investor Relations Department
Email: ir@workmedtech.com
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
FAQ
What is the purpose of WORK Medical’s (WOK) partnership with Xin Rui Hospital?
The partnership aims to develop AI-powered medical products and advance hospital informatization by integrating AI technology with Xin Rui Hospital’s multimodal medical resources, including text, imaging, and laboratory data.
How will WORK Medical (WOK) benefit from the Xin Rui Hospital collaboration?
WORK Medical will gain access to Xin Rui Hospital’s clinical data and practical environment to enhance its multimodal universal medical AI solution, expand beyond single-image data, and accelerate AI transformation in domestic hospitals.
What type of AI solutions will WORK Medical (WOK) develop with Xin Rui Hospital?
The company will develop multimodal AI solutions that integrate text, imaging, and laboratory data, creating a comprehensive framework for data governance, model training, and clinical practice implementation.
Who is Xin Rui Hospital and what is their significance in this partnership?
Xin Rui Hospital is a Grade 3-Class B tertiary hospital in Wuxi, China, affiliated with Ruijin Hospital-Shanghai Jiao Tong University School of Medicine, one of China’s premier medical institutions and a National Clinical Research Center.
